Nektar Therapeutics

NASDAQ: NKTR
Share price (1/7/26): $43.51
Market cap (1/7/26): $855 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Zalevsky Jonathan

Wilson Mark Andrew

Zalevsky Jonathan

News Filter

REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-Of-Concept in Patients With Severe-To-Very-Severe Alopecia Areata

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

New Data From REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

Reports Third Quarter 2025 Financial Results

Presents New Data From REZOLVE-AD Phase 2b Study for Rezpegaldesleukin in Late-Breaker Oral Presentation at EADV 2025

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness